DK0956023T3 - Anvendelse af progesteron til behandling eller reduktion af iskæmi hos menopausale kvinder, der modtager estrogen - Google Patents

Anvendelse af progesteron til behandling eller reduktion af iskæmi hos menopausale kvinder, der modtager estrogen

Info

Publication number
DK0956023T3
DK0956023T3 DK97946681T DK97946681T DK0956023T3 DK 0956023 T3 DK0956023 T3 DK 0956023T3 DK 97946681 T DK97946681 T DK 97946681T DK 97946681 T DK97946681 T DK 97946681T DK 0956023 T3 DK0956023 T3 DK 0956023T3
Authority
DK
Denmark
Prior art keywords
progesterone
treat
menopausal women
women receiving
reduce ischemia
Prior art date
Application number
DK97946681T
Other languages
Danish (da)
English (en)
Inventor
Howard L Levine
William J Bologna
Original Assignee
Columbia Lab Bermuda Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Family has litigation
First worldwide family litigation filed litigation Critical https://patents.darts-ip.com/?family=24987712&utm_source=google_patent&utm_medium=platform_link&utm_campaign=public_patent_search&patent=DK0956023(T3) "Global patent litigation dataset” by Darts-ip is licensed under a Creative Commons Attribution 4.0 International License.
Application filed by Columbia Lab Bermuda Ltd filed Critical Columbia Lab Bermuda Ltd
Application granted granted Critical
Publication of DK0956023T3 publication Critical patent/DK0956023T3/da

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/56—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids
    • A61K31/57—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids substituted in position 17 beta by a chain of two carbon atoms, e.g. pregnane or progesterone
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A61P9/10—Drugs for disorders of the cardiovascular system for treating ischaemic or atherosclerotic diseases, e.g. antianginal drugs, coronary vasodilators, drugs for myocardial infarction, retinopathy, cerebrovascula insufficiency, renal arteriosclerosis

Landscapes

  • Health & Medical Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • General Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Chemical & Material Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Epidemiology (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Vascular Medicine (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Urology & Nephrology (AREA)
  • Cardiology (AREA)
  • Organic Chemistry (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Steroid Compounds (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
DK97946681T 1996-11-04 1997-11-04 Anvendelse af progesteron til behandling eller reduktion af iskæmi hos menopausale kvinder, der modtager estrogen DK0956023T3 (da)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US08/743,153 US5985861A (en) 1996-11-04 1996-11-04 Progesterone for treating or reducing ischemia

Publications (1)

Publication Number Publication Date
DK0956023T3 true DK0956023T3 (da) 2006-08-07

Family

ID=24987712

Family Applications (1)

Application Number Title Priority Date Filing Date
DK97946681T DK0956023T3 (da) 1996-11-04 1997-11-04 Anvendelse af progesteron til behandling eller reduktion af iskæmi hos menopausale kvinder, der modtager estrogen

Country Status (27)

Country Link
US (2) US5985861A (es)
EP (1) EP0956023B1 (es)
KR (1) KR100434623B1 (es)
CN (1) CN100341512C (es)
AR (1) AR009407A1 (es)
AT (1) ATE321558T1 (es)
AU (1) AU715740C (es)
BR (1) BR9710918A (es)
CA (1) CA2270565C (es)
DE (1) DE69735598T2 (es)
DK (1) DK0956023T3 (es)
ES (1) ES2262196T3 (es)
GE (1) GEP20022630B (es)
HK (1) HK1020534A1 (es)
HU (1) HUP9904045A3 (es)
IL (1) IL127455A (es)
LV (1) LV12342B (es)
MA (1) MA24391A1 (es)
MY (1) MY121627A (es)
NO (1) NO324278B1 (es)
NZ (1) NZ335306A (es)
PE (1) PE9899A1 (es)
PT (1) PT956023E (es)
RO (1) RO120607B1 (es)
UA (1) UA66772C2 (es)
WO (1) WO1998019681A1 (es)
ZA (1) ZA979862B (es)

Families Citing this family (33)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US6056972A (en) * 1997-02-26 2000-05-02 Dimera, Llc Method for reducing coronary artery reactivity
US6602487B1 (en) 1997-02-26 2003-08-05 Dimera Incorporated Methods and tests for producing and for inhibiting coronary artery vasospasms
DE69819748T2 (de) 1997-09-12 2004-09-30 Columbia Laboratories (Bermuda) Ltd. Arzneimittel zur behandlung von dysmenorrhöe und verfrühten wehen
US20040234606A1 (en) * 1997-09-12 2004-11-25 Levine Howard L. Localized vaginal delivery without detrimental blood levels
GB0107383D0 (en) * 2001-03-23 2001-05-16 Univ Edinburgh Lipid profile modulation
US8425892B2 (en) 2001-10-29 2013-04-23 Columbia Laboratories, Inc. Extended, controlled-release pharmaceutical compositions using charged polymers
US20080182841A1 (en) * 2001-10-29 2008-07-31 Levine Howard L Vaginally administered anti-dysrhythmic agents for treating pelvic pain
US20030114394A1 (en) * 2001-10-29 2003-06-19 Levine Howard L. Vaginally administered anti-dysrhythmic agents for treating pelvic pain
US7572780B2 (en) 2003-01-21 2009-08-11 Dimera, Incorporated Method and kit for reducing the symptoms of peripheral vascular disease
AU2004233997C1 (en) * 2003-04-29 2014-01-30 Massachusetts Institiute Of Technology Methods and devices for the sustained release of multiple drugs
DE102005027004B4 (de) * 2005-06-10 2020-03-19 Continental Automotive Gmbh Scheibenwaschvorrichtung
US8828981B2 (en) 2007-02-06 2014-09-09 George Creasy Progesterone for the treatment or prevention of spontaneous preterm birth
SI2359807T1 (sl) 2008-02-04 2017-10-30 Ferring B.V. Monolitni intravaginalni obroč, ki vsebuje progesteron ter postopki za njegovo izdelavo in uporabo
CA2856520C (en) 2011-11-23 2021-04-06 Therapeuticsmd, Inc. Natural combination hormone replacement formulations and therapies
US9301920B2 (en) 2012-06-18 2016-04-05 Therapeuticsmd, Inc. Natural combination hormone replacement formulations and therapies
US20130338122A1 (en) 2012-06-18 2013-12-19 Therapeuticsmd, Inc. Transdermal hormone replacement therapies
US20150196640A1 (en) 2012-06-18 2015-07-16 Therapeuticsmd, Inc. Progesterone formulations having a desirable pk profile
US10806740B2 (en) 2012-06-18 2020-10-20 Therapeuticsmd, Inc. Natural combination hormone replacement formulations and therapies
US10806697B2 (en) 2012-12-21 2020-10-20 Therapeuticsmd, Inc. Vaginal inserted estradiol pharmaceutical compositions and methods
US11266661B2 (en) 2012-12-21 2022-03-08 Therapeuticsmd, Inc. Vaginal inserted estradiol pharmaceutical compositions and methods
US10537581B2 (en) 2012-12-21 2020-01-21 Therapeuticsmd, Inc. Vaginal inserted estradiol pharmaceutical compositions and methods
US11246875B2 (en) 2012-12-21 2022-02-15 Therapeuticsmd, Inc. Vaginal inserted estradiol pharmaceutical compositions and methods
US10568891B2 (en) 2012-12-21 2020-02-25 Therapeuticsmd, Inc. Vaginal inserted estradiol pharmaceutical compositions and methods
US10471072B2 (en) 2012-12-21 2019-11-12 Therapeuticsmd, Inc. Vaginal inserted estradiol pharmaceutical compositions and methods
US9180091B2 (en) 2012-12-21 2015-11-10 Therapeuticsmd, Inc. Soluble estradiol capsule for vaginal insertion
AU2015264003A1 (en) 2014-05-22 2016-11-17 Therapeuticsmd, Inc. Natural combination hormone replacement formulations and therapies
KR20170040209A (ko) 2014-07-29 2017-04-12 쎄러퓨틱스엠디, 인코퍼레이티드 경피 크림
US10328087B2 (en) 2015-07-23 2019-06-25 Therapeuticsmd, Inc. Formulations for solubilizing hormones
WO2017173044A1 (en) 2016-04-01 2017-10-05 Therapeuticsmd Inc. Steroid hormone compositions in medium chain oils
CA3020153A1 (en) 2016-04-01 2017-10-05 Therapeuticsmd, Inc. Steroid hormone pharmaceutical composition
JP2021535183A (ja) 2018-09-07 2021-12-16 トラスティーズ・オヴ・ダートマス・カレッジ Ｃ１９骨格およびステロイドならびにそれらの使用および製造方法
US11512107B2 (en) 2018-09-07 2022-11-29 Trustees Of Dartmouth College Methods for assembly of tetracyclic compounds by stereoselective C9-C10 bond formation
US11633405B2 (en) 2020-02-07 2023-04-25 Therapeuticsmd, Inc. Steroid hormone pharmaceutical formulations

Family Cites Families (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
SU1124906A1 (ru) * 1982-05-25 1984-11-23 Ивановский государственный медицинский институт им.А.С.Бубнова Способ коррекции ишемических повреждений консервированной донорской почки
EP0501523B1 (en) * 1983-11-14 1997-04-09 Columbia Laboratories, Inc. Bioadhesive compositions
US5543150A (en) * 1993-09-15 1996-08-06 Columbia Laboratories, Inc. Method of progesterone delivery and affect thereof

Also Published As

Publication number Publication date
ZA979862B (en) 1998-05-25
US6054447A (en) 2000-04-25
US5985861A (en) 1999-11-16
LV12342A (lv) 1999-09-20
AU715740C (en) 2004-04-29
AU5180198A (en) 1998-05-29
EP0956023B1 (en) 2006-03-29
KR20000053056A (ko) 2000-08-25
MA24391A1 (fr) 1998-07-01
CA2270565A1 (en) 1998-05-14
IL127455A (en) 2005-03-20
CN100341512C (zh) 2007-10-10
PE9899A1 (es) 1999-02-08
NO992140L (no) 1999-05-04
HUP9904045A3 (en) 2000-11-28
HUP9904045A2 (hu) 2000-04-28
NO992140D0 (no) 1999-05-03
ES2262196T3 (es) 2006-11-16
IL127455A0 (en) 1999-10-28
NZ335306A (en) 2000-12-22
DE69735598D1 (de) 2006-05-18
NO324278B1 (no) 2007-09-17
GEP20022630B (en) 2002-02-25
RO120607B1 (ro) 2006-05-30
LV12342B (en) 2000-01-20
ATE321558T1 (de) 2006-04-15
EP0956023A1 (en) 1999-11-17
BR9710918A (pt) 2000-01-11
DE69735598T2 (de) 2006-12-28
AU715740B2 (en) 2000-02-10
MY121627A (en) 2006-02-28
KR100434623B1 (ko) 2004-06-05
WO1998019681A1 (en) 1998-05-14
HK1020534A1 (en) 2000-05-12
CN1235549A (zh) 1999-11-17
AR009407A1 (es) 2000-04-12
PT956023E (pt) 2006-08-31
UA66772C2 (uk) 2004-06-15
CA2270565C (en) 2007-02-20

Similar Documents

Publication Publication Date Title
DK0956023T3 (da) Anvendelse af progesteron til behandling eller reduktion af iskæmi hos menopausale kvinder, der modtager estrogen
DK0930876T3 (da) Anvendelse af forbindelser, der fremmer estrogen aktivitet, til behandling af sår
DK0748190T3 (da) Progestogenfrie formuleringer af GnRH og estrogen til behandling af benigne gynækologiske lidelser
DK0849554T3 (da) Installation til behandling af fødevarer styret i forhold til referenceparametre
DE69712210D1 (de) Abnehmbare integrierte flugzeugheckkonus und -hilfskrafteinheit
DK1023067T4 (da) Anvendelse af inhibitorer af renin-angiotensin-systemet til behandling af hypoxi eller svækket metabolisk funktion
DE60028276D1 (de) Verringerung von Verzögerung in Mehrträgerempfängern
DE69621801D1 (de) Zusammensetzung Enthaltend Isoflavon zur Förderung von Fettabbau im Fettzellen
ID18072A (id) Komposisi kosmetik berair untuk kulit
GB9618532D0 (en) Improvements relating to sock applying aids
DE59704171D1 (de) Retarder
FR2744714B1 (fr) Auxiliaire de broyage du ciment
BR9606549A (pt) Uso de uma mistura estro-progestogênica para tratamento de deficiéncias de estrogeno em mulheres menopausais composiç o estrogênica composiçao estro-progestogênica e processo para preparaçao de uma composiçao estrogênica
NO985029D0 (no) Forbedring av, eller med hensyn til, synkronisering
BG102771A (en) Diarylmethylidenfuran derivatives, method for their preparation and utilization as medicamentous forms
NO985030D0 (no) Forbedring av, eller med hensyn til, synkronisering
DK1054691T3 (da) Antienzym-antistoffer til behandling af huden
AU2624299A (en) Necrosis-affine compounds and the utilization thereof in order to produce preparations for pharmacotherapy
NO985178D0 (no) Forbedring av eller vedr°rende tale-til-taleomforming
GB9723179D0 (en) Self-adhesive patch for application to the skin
DK0974231T3 (da) Forbindelsestilpasning i relation til radio
IS1534B (is) Fyrirkomulag stýrikerfis öngla, svonefndur aðgreinir, til nota í togkerfilínu
EP0987849A4 (en) DIRECT DISPERSE SPECTRUM COMMUNICATION SYSTEM CORRESPONDING TO TIMED MULTIPLEX MODE, AND COMMUNICATION METHOD USING THE SYSTEM
DE29611245U1 (de) Regenwasser-Nutzungsanlage
ID16153A (id) (Z)-11β-[[4-DIMETILAMINO) PENIL]17β-HIDROKSI-17α-(3-HIDROKSI-1-PROPENIL) ESTER-4-EN-3-SATU SEBAGAI ANSOLVAT BERBENTUK KRISTAL